2. Academic Validation
  3. In-frame germline TP53 variant impairs p53 oligomerization and predisposes to cancer

In-frame germline TP53 variant impairs p53 oligomerization and predisposes to cancer

  • Sci Rep. 2025 Aug 19;15(1):30459. doi: 10.1038/s41598-025-14684-8.
Lucie Vanikova 1,  Eva Machackova 2,  Barbora Nemcova 3,  Jana Soukupova 3 4,  Silvia Petrezselyova 1,  Klara Novakova 2,  Marcela Zenatova 5,  Sarka Pavlova 5 6,  Petra Kleiblova 3 4,  Zdenek Kleibl 3 7,  Lenka Foretova 2,  Libor Macurek 8
Affiliations

Affiliations

  • 1 Cancer Cell Biology, Institute of Molecular Genetics of the Czech Academy of Sciences, 14220, Prague, Czech Republic.
  • 2 Masaryk Memorial Cancer Institute, Brno, Czech Republic.
  • 3 Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
  • 4 Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
  • 5 Department of Internal Medicine, Hematology and Oncology, and Institute of Medical Genetics and Genomics, University Hospital Brno and Medical Faculty, Masaryk University, Brno, Czech Republic.
  • 6 Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic.
  • 7 Department of Pathophysiology, First Faculty of Medicine, Charles University, Prague, Czech Republic.
  • 8 Cancer Cell Biology, Institute of Molecular Genetics of the Czech Academy of Sciences, 14220, Prague, Czech Republic. libor.macurek@img.cas.cz.
PMID: 40830167 DOI: 10.1038/s41598-025-14684-8
Abstract

Germline loss-of-function variants in TP53 cause Li-Fraumeni syndrome (LFS) characterized by an early onset of various Cancer types including sarcomas, adrenocortical carcinoma, and breast Cancer. The most common are mutations in the DNA binding domain of p53, but alterations in the oligomerization domain also cause LFS with variable level of penetrance. Here we report identification of a novel germline in-frame deletion TP53 variant c.1015_1023del p.(E339_F341del) in a family with early-onset breast Cancer and Other malignancies. Using functional testing, we found that a short deletion in the oligomerization domain in the p.E339_F341del variant severely impaired transcriptional activity of p53 in human cells and in a yeast model. The loss of the transactivation activity was consistent with an observed defect in formation of p53 tetramers. Finally, we found that cells expressing the p.E339_F341del variant were insensitive to inhibition of MDM2 by nutlin-3 confirming the functional defect. We conclude that the in-frame germline c.1015_1023del TP53 variant encodes a transcriptionally inactive protein and promotes LFS with a high penetrant Cancer phenotype.

Keywords

Cancer; Li Fraumeni syndrome; TP53; p53.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z